InsiderTrades.com logo
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.

RAPP Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $1,079,664.64
Insider Selling (Last 12 Months): $0.00

Rapport Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Rapport Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Rapport Therapeutics Share Price & Price History

Current Price: $18.07
Price Change: ▲ Price Increase of +0.21 (1.18%)
As of 12/20/2024 06:16 PM ET

This chart shows the closing price history over time for RAPP up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis
From Weiss Ratings   |   Ad
Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …
Find out details on these three critical Nvidia partners immediately.

Rapport Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/1/2024James HealyDirectorBuy44,032$24.52$1,079,664.6440,851View SEC Filing Icon  
See Full Table
Did You See Trump’s Bombshell Exec. Order 001?
From Banyan Hill Publishing   |   Ad
Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minutes of stepping into the Oval Office...
I put all the details together for you here — but please hurry. 

SEC Filings (Institutional Ownership Changes) for Rapport Therapeutics (NASDAQ:RAPP)

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at RAPP by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Rapport Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/19/2024Barclays PLC12,863$0.26M0.0%+36.8%0.035%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC201,748$4.13M0.0%N/A0.552%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC12,863$0.26M0.0%+36.8%0.035%Search for SEC Filing on Google Icon
11/15/2024State Street Corp58,046$1.19M0.0%N/A0.159%Search for SEC Filing on Google Icon
11/15/2024Maven Securities LTD29,930$0.61M0.0%N/A0.082%Search for SEC Filing on Google Icon
11/14/2024Eventide Asset Management LLC110,401$2.26M0.0%+120.8%0.302%Search for SEC Filing on Google Icon
11/14/2024Acuta Capital Partners LLC17,600$0.36M0.3%-12.0%0.048%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC5,710$0.12M0.0%N/A0.016%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets1,684$34K0.0%N/A0.005%Search for SEC Filing on Google Icon
11/13/2024FMR LLC5,486,468$112.36M0.0%+10.1%14.999%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company77,344$1.58M0.0%+2.4%0.211%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.73,146$1.50M0.0%N/A0.200%Search for SEC Filing on Google Icon
11/7/2024LMR Partners LLP20,000$0.41M0.0%-60.0%0.055%Search for SEC Filing on Google Icon
10/23/2024Values First Advisors Inc.1,507$31K0.0%N/A0.004%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC4,934$0.10M0.0%N/A0.014%Search for SEC Filing on Google Icon
8/27/2024Logos Global Management LP208,910$4.86M0.4%N/A0.591%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC748,183$17.40M0.4%N/A2.045%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company75,516$1.76M0.0%N/A0.206%Search for SEC Filing on Google Icon
8/15/2024Millennium Management LLC116,782$2.72M0.0%N/A0.319%Search for SEC Filing on Google Icon
8/14/2024Squarepoint Ops LLC16,345$0.38M0.0%N/A0.045%Search for SEC Filing on Google Icon
8/14/2024Sandia Investment Management LP5,000$0.12M0.2%N/A0.014%Search for SEC Filing on Google Icon
8/14/2024ARCH Venture Management LLC3,728,738$86.73M31.6%N/A10.193%Search for SEC Filing on Google Icon
8/14/2024Davidson Kempner Capital Management LP10,000$0.23M0.0%N/A0.027%Search for SEC Filing on Google Icon
8/10/2024Sofinnova Investments Inc.1,951,562$45.39M2.4%N/A5.516%Search for SEC Filing on Google Icon
8/9/2024Johnson & Johnson2,498,051$58.11M14.5%N/A7.061%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc101,522$2.36M0.0%N/A0.287%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Rapport Therapeutics logo
Rapport Therapeutics Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.
Read More on Rapport Therapeutics

Today's Range

Now: $18.07
Low: $17.52
High: $19.08

50 Day Range

MA: $22.97
Low: $17.86
High: $29.23

52 Week Range

Now: $18.07
Low: $16.55
High: $29.74

Volume

527,558 shs

Average Volume

155,880 shs

Market Capitalization

$660.93 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Rapport Therapeutics?

Rapport Therapeutics' top insider shareholders include:
  1. James Healy (Director)
Learn More about top insider investors at Rapport Therapeutics.

Who are the major institutional investors of Rapport Therapeutics?

Rapport Therapeutics' top institutional shareholders include:
  1. FMR LLC — 15.00%
  2. Geode Capital Management LLC — 0.55%
  3. Eventide Asset Management LLC — 0.30%
  4. The Manufacturers Life Insurance Company — 0.21%
  5. Charles Schwab Investment Management Inc. — 0.20%
  6. State Street Corp — 0.16%
Learn More about top institutional investors of Rapport Therapeutics stock.

Which major investors are selling Rapport Therapeutics stock?

In the previous quarter, RAPP stock was sold by these institutional investors:
  1. LMR Partners LLP
  2. Acuta Capital Partners LLC

Which major investors are buying Rapport Therapeutics stock?

Within the last quarter, RAPP stock was acquired by institutional investors including:
  1. FMR LLC
  2. Geode Capital Management LLC
  3. Charles Schwab Investment Management Inc.
  4. Eventide Asset Management LLC
  5. State Street Corp
  6. Maven Securities LTD
  7. MetLife Investment Management LLC
  8. SG Americas Securities LLC
Missed Nvidia? Buy Elon Musk’s “Silent Partner”
From Brownstone Research   |   Ad
In February 2016, when almost nobody was talking about artificial intelligence… I picked Nvidia as one of my favorite stocks. Today, it’s probably the most popular stock in the world. I believe this Elon Musk “silent partner” could be the next big AI winner.
So please click here to see the details because a lot of people could get rich.